US HB1781 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 22-8)
Status: Engrossed on October 29 2019 - 50% progression, died in committee
Action: 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on October 29 2019 - 50% progression, died in committee
Action: 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Title
Payment Commission Data Act of 2019
Sponsors
Rep. Earl Carter [R-GA] | Rep. Tom O'Halleran [D-AZ] | Rep. Tom Rice [R-SC] | Rep. Jimmy Panetta [D-CA] |
Rep. Greg Gianforte [R-MT] | Sen. Peter Welch [D-VT] | Rep. Frank Pallone [D-NJ] | Rep. Raul Ruiz [D-CA] |
Rep. Bobby Rush [D-IL] | Rep. Debbie Dingell [D-MI] | Rep. Anna Eshoo [D-CA] | Rep. Joseph Kennedy [D-MA] |
Rep. Doris Matsui [D-CA] | Rep. Gus Bilirakis [R-FL] | Rep. Jeff Van Drew [R-NJ] | Rep. Janice Schakowsky [D-IL] |
Rep. Greg Walden [R-OR] | Rep. Yvette Clarke [D-NY] | Rep. Tim Burchett [R-TN] | Rep. Debbie Mucarsel-Powell [D-FL] |
Sen. Andy Kim [D-NJ] | Rep. Sean Casten [D-IL] | Rep. Gerald Connolly [D-VA] | Rep. Gil Cisneros [D-CA] |
Rep. Ann Wagner [R-MO] | Rep. Lauren Underwood [D-IL] | Rep. Greg Stanton [D-AZ] | Sen. Elissa Slotkin [D-MI] |
Rep. Angela Craig [D-MN] | Rep. Abigail Spanberger [D-VA] |
History
Date | Chamber | Action |
---|---|---|
2019-10-29 | Senate | Received in the Senate and Read twice and referred to the Committee on Finance. |
2019-10-28 | House | Motion to reconsider laid on the table Agreed to without objection. |
2019-10-28 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526) |
2019-10-28 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 1781. |
2019-10-28 | House | Considered under suspension of the rules. (consideration: CR H8526-8527) |
2019-10-28 | House | Ms. Schakowsky moved to suspend the rules and pass the bill, as amended. |
2019-10-28 | House | Placed on the Union Calendar, Calendar No. 205. |
2019-10-28 | House | Committee on Ways and Means discharged. |
2019-10-28 | House | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I. |
2019-04-03 | House | Ordered to be Reported (Amended) by Voice Vote. |
2019-04-03 | House | Committee Consideration and Mark-up Session Held. |
2019-03-27 | House | Forwarded by Subcommittee to Full Committee by Voice Vote . |
2019-03-27 | House | Subcommittee Consideration and Mark-up Session Held. |
2019-03-15 | House | Referred to the Subcommittee on Health. |
2019-03-14 | House | Referred to the Subcommittee on Health. |
2019-03-14 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-03-14 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-03-14 | House | Introduced in House |
Same As/Similar To
HB1264 (Same As) 2019-02-15 - Referred to the Subcommittee on Health.
SB801 (Related) 2019-03-14 - Read twice and referred to the Committee on Finance.
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
SB4199 (Related) 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)
SB801 (Related) 2019-03-14 - Read twice and referred to the Committee on Finance.
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
SB4199 (Related) 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)
Subjects
Advisory bodies
Health
Health care costs and insurance
Health information and medical records
Health programs administration and funding
Medicaid
Medicare
Prescription drugs
Health
Health care costs and insurance
Health information and medical records
Health programs administration and funding
Medicaid
Medicare
Prescription drugs